Jobs at GenoEmote

GenoEmote, LLC is a thought-leader in brain-computer interface (BCI) technology to address the extreme level of stress affecting human mental health. What is BCI? It's new technology to measure, analyze and develop communication between the brain and a computer to not only understand the brain better but how to improve its function and by extension improve the human condition. What problem is GenoEmote solving? Stress is no longer manageable -> Help can’t scale -> Stress leads to disease One only needs to read the recent survey, “Stress in America: January 2021 Stress Snapshot,” by the American Psychological Association (APA) to understand the extreme need for scalable solutions to reduce stress caused by the pandemic and related social and cultural upheaval. GenoEmote has a multi-product roadmap fueled by our patent-pending BCI technology, with the first two products targeted to launch in 2022. • CoreEmpower (Q2 2022) helps leaders reflect on their performance and improve their capabilities by identifying and modifying inhibiting perceptions to empowering ones. • Third-I, a pocket therapist (Q3 2022) leads a line of questioning using brain wave analysis to compare the conscious answer given against the unconscious answer. Third-I gives power to the user to modify unwanted or inhibiting perceptions, encouraging a higher level of self-awareness and a reduction in stress. Our team is lined up, go-to-market development is underway, prototype release is imminent…and we are now looking to raise $350,000 in a seed round to fuel our launch.